Cognizant stated that it is collaborating with Boehringer Ingelheim, a top biopharmaceutical business known for its commitment to research, to improve the quality and speed of the development of pharmaceutical therapies. Using Veeva's (NYSE: VEEV) Development Cloud, Cognizant will work with Boehringer Ingelheim to integrate data and procedures related to the development of pharmaceuticals into a networked technological ecosystem, fostering improved communication between clinical, regulatory, and quality activities.

 

"Achieving an end-to-end platform to help speed the development of life-changing therapies has been an elusive goal for many organizations, and we're making that vision a reality," said Uli BrÓ§dl, Senior Vice President, Global Clinical Development at Boehringer Ingelheim. "Our collaborations with Cognizant and Veeva are empowering us to advance this important program that will positively impact patient lives."

 

Boehringer Ingelheim's connected ecosystem, dubbed the "One Medication Platform," is anticipated to be one of the biggest global Veeva technology implementations. This comprehensive strategy is designed to boost operational efficiency by integrating clinical, regulatory, and quality services from Boehringer Ingelheim onto one platform at once.

 

The Boehringer Ingelheim engagement was started by Cognizant with an examination of the business and technology of the biopharmaceutical firm. This was followed by the creation of the programme plan and the agile methodology for system integration. Program management, system architecture and design, training, data migration, integration, testing, and validation services are among the services that Cognizant is currently putting into practise in collaboration with Veeva. 

 

"Utilizing advanced technologies to improve the quality and delivery of novel medicines is a must for innovative pharmaceutical companies, and Boehringer Ingelheim stands out for their forward thinking in pursuing development of the One Medicine Platform," said Srini Shankar, Global Head of Cognizant Life Sciences. "Veeva has been recognized as one of the fastest growing life sciences technology companies, and Cognizant is a skilled system integrator with the expertise necessary to simultaneously implement multiple Veeva platforms. We are proud to be working together to set new precedents in the way clinical, regulatory, and quality functions come together to help accelerate the delivery of new life-saving therapies."